Navigation Links
NeoStem Featured in Business Week; 'Promising' Adult Stem Cell Market Discussed in Fortune-CNNMoney.com Article
Date:6/22/2009

n important research and therapeutic company by identifying, collecting and concentrating these unique cells for delivery when the person needs them in the future. Compared to embryonic stem cells, these cells are one's own and are not subject to risk of rejection nor require immune suppressing drugs and could remove any ethical dilemmas surrounding embryonic stem cell research or treatment. The Company anticipates accelerating its revenue growth by acquiring new stem cell therapeutic technologies and expanding its IP portfolio.

"We believe clinical application of NeoStem's proprietary technologies, including its Very Small Embryonic Like (VSEL) adult stem cell technology, should accelerate dramatically in China over the next several years," said Jackson Ling, Chairman of Enhance Biomedical Holdings Limited a recent investor in the Company and strategic partner with which NeoStem recently entered into a 10-year agreement to develop a Stem Cell Collection and Treatment Network utilizing NeoStem's proprietary adult stem cell technologies in certain territories n Asia.

About NeoStem, Inc.

NeoStem is developing a network of adult stem cell collection centers that are focused on enabling people to donate and store their own (autologous) stem cells when they are young and healthy for their personal use in times of future medical need. The Company has also entered into research and development through the acquisition of a worldwide exclusive license to technology to identify and isolate VSELs (very small embryonic-like stem cells), which have been shown to have several physical characteristics that are generally found in embryonic stem cells and is pursuing other technologies to advance its position in the field of stem cell tissue regeneration.

For more information, please visit: www.neost
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. NeoStem Announces NY State License for Adult Stem Cell Collection
2. NeoStem to Present at Third Annual Stem Cell Summit in New York City
3. NeoStems Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus
4. NeoStem Featured in WCBS-TV Health Watch Segment on Adult Stem Cells
5. NeoStem to Expand Stem Cell Collection Center Network to Florida
6. NeoStem Announces Private Placement Financing to Advance Marketing Campaign; Financing Includes Investment from New England Cryogenic Center
7. Suzanne Somers To Promote Growing Importance of Storing Your Own Adult Stem Cells Under Alliance With NeoStem, Inc.
8. NeoStem Expands Adult Stem Cell Collection Network, Gains Footprint in Key Los Angeles Market and Initiates Waitlist
9. NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide
10. Suzanne Somers, Renowned Author, Medical Advocate, and Official Spokesperson for NeoStem, Inc., Inspires the Audience on The Ellen Degeneres Show
11. NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Selexis SA, a serial ... Cell Banks (RCBs) used for drug discovery to commercial ... will include Next-Generation Sequencing (NGS) data packages. ... biologic manufacturing by ensuring the integrity of the gene, ...
(Date:1/22/2015)... Medical Systems (NYSE: VAR ), world leader in ... to sustainability with inclusion on a prestigious list of the ... equipment company among the Corporate Knights Global 100 Most Sustainable ... Davos, Switzerland . "We ...
(Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
(Date:12/24/2014)... 2014 “Preparative & Process Chromatography ... Consumables (Columns, Solvents, Buffers, Valves, Guages, Seals), Accessories, ... - Forecasts to 2019” provides a detailed overview ... market trends, and strategies impacting the preparative and ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4
... Even with layoff announcements from more than a dozen employers in health ... in the past month it seemed like no one was searching for ... ... Strong growth continues in the health care field, with an average of ...
... PHILADELPHIA, Oct. 30 AVAX Technologies, Inc.,(OTC Bulletin ... October,24, 2008, it closed a bridge loan financing ... as amended by the Amendment to Convertible,Note and ... Agreement, the Company sold convertible promissory notes,(the "Notes") ...
... N.J., Oct. 30 Medarex, Inc.,(Nasdaq: MEDX ) announced ... Medarex,s net loss for the quarter ended September 30, ... a net loss of $51.6 million,or ($0.41) per share, for ... a non-cash charge of $5.4 million, or ($0.04) per share, ...
Cached Biology Technology:The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health 2The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health 3AVAX Technologies, Inc. Announces Closing of Bridge Loan Financing 2Medarex Announces 2008 Third Quarter Financial Results 2Medarex Announces 2008 Third Quarter Financial Results 3Medarex Announces 2008 Third Quarter Financial Results 4Medarex Announces 2008 Third Quarter Financial Results 5Medarex Announces 2008 Third Quarter Financial Results 6Medarex Announces 2008 Third Quarter Financial Results 7Medarex Announces 2008 Third Quarter Financial Results 8Medarex Announces 2008 Third Quarter Financial Results 9
(Date:12/17/2014)... Valencell, a leader in performance biometric data sensor technology, ... such as Intel, Jabra, Atlas, and Scosche to develop ... products will be showcased at CES 2015, taking place ... "Our partners choose PerformTek biometrics, because ...
(Date:12/17/2014)... DENVER , Dec. 16, 2014  Automation is fundamentally ... evident than at international borders. Over the past decade, ... veteran travelers to self process through border control via ... increasing number of airports, seaports, and land borders across ...
(Date:12/11/2014)... Research and Markets , ... announced the addition of the "Biometrics Market in ... One major trend emerging in this market ... it is important to upgrade biometric solutions to the ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... over, oil, gasoline, and coal. Researchers are describing key ... energy-hungry world in the 21st Century in the eighth ... Challenges/Chemistry Solutions series. Those fuels include "green gasoline," "designer ... can help power an energy-hungry world into the future. ...
... been a focal point of recent climate change research because ... the larger Antarctic ice sheet. Yet while the southern Greenland ... how much this is contributing to rising sea levels, and ... was defined at a recent workshop organised by the European ...
... N.J. and Jamaica Plain, Mass., November 3, 2008 ... Biologic Laboratories (MBL) of the University of Massachusetts ... 2 trial of an anti- C. difficile ... difficile Associated Diarrhea (CDAD) successfully met its ...
Cached Biology News:Fuels of the future may come from 'ice that burns,' water and sunshine 2What is really happening to the Greenland icecap? 2Positive results in Phase 2 trial of treatment of C-difficile-associated diarrhea 2Positive results in Phase 2 trial of treatment of C-difficile-associated diarrhea 3
No description available in Ensembl Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
No description available in Ensembl. Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
12(S)-HETE-d8 is used as an internal standard for the quantification of 12(S)-HETE by stable isotope dilution mass spectrometry....
...
Biology Products: